“…The overall prevalence of anti-HBc among volunteer blood donors using ra dioimmunoassay or complement fixation tests has been reported as 2.3% in The Neth erlands [10], 15.3% in Greece [15], 33.3% in Italy [2], and 2.7% in the United States [16], The prevalence of anti-HBc among blood donors in 13 countries in the western hemi sphere was 21%, and 5.3% of all blood do nors had anti-HBc as the sole marker of HBV infection [12], A higher prevalence of anti-HBc has been reported in volunteer blood donors who present with a history of hepatitis or transfusion [17] and among some US military populations [8], The observed prevalence of HBsAg is significantly affected by the donor selection practices and depends upon the proportion of blood collected at a particular type of site, e.g., schools and col leges, plants and factories, on military bases, etc., which in turn reflects the different so cioeconomic status of the donor populations [3]. It is not clear from the data available to us if the lower prevalence of anti-HBc in Boston reported here was due to the differ ences in the type of blood collection sites.…”